Oxford Biosensors Ltd Company Profile

16:39 EDT 20th June 2018 | BioPortfolio

Since formation in 2000, Oxford Biosensors has invested significant resources into the commercialisation of biosensor technology. The groundbreaking technical advances achieved through an intensive R & D programme have resulted in the development of a range of low complexity, hand-held diagnostic products.
Set to satisfy the demand for fast and accurate multi-parameter analysis at the point of care, the company's Multisense dry enzyme system provides essential diagnostic results instantly.
Oxford Biosensors' interdisciplinary development programme is led by top research and development scientists and brings together expertise in electronics, materials science, electrochemistry and enzyme technology. In addition, a group of respected and internationally recognised experts sit on the company's advisory boards alongside other distinguished academics and medics.


Oxford Industrial Park Mead Road
United Kingdom


Phone: 44 (0)1865 849 100
Fax: 44 (0)1865 849 200

News Articles [338 Associated News Articles listed on BioPortfolio]

Biosensors Bring HIV Test to Patients for Instant Results

A report on the use of biosensors in molecular disease diagnostics states the technology could significantly reduce the spread of HIV. A report by Cambridge-based IDTechEx analyzed important trends i...

Oxford Centre for Haematology launched

The new Oxford Centre for Haematology has been launched with funding from the NIHR Oxford Biomedical Research Centre (BRC), bringing together University of Oxford researchers and clinicians from Oxfor...

Easy printing of biosensors made of graphene

Cell-based biosensors can simulate the effect of various substances, such as drugs, on the human body in the laboratory. Depending on the measuring principle, though, producing them can be expensive....

Transcription factor‐based biosensors in high‐throughput screening: advances and applications

The molecular mechanisms that cells use to sense changes in the intra‐ and extracellular environment are increasingly utilized in synthetic biology to build genetic reporter constructs for various a...

Oxford Keeps Growing as a Hotspot for Cancer Vaccines with New Fundraising

Oxford Vacmedix has secured $12.5M (€10M) to start its first clinical trials, joining other Oxford-based biotechs in the cancer vaccine field such as Vaccitech and SpyBiotech. Oxford Vacmedix has s...

Determining the Optimal Biomarker Frequency for Biosensors

Chi-En Lin won Metrohm’s Young Chemist of the Year award for his research into optimal biomarker frequencies, not just the novelty of the research but how it can be applied. Determining optimal biom...

DNA Sequencing Unicorn Oxford Nanopore Raises £100M round at £1.5B valuation

Undeterred by competitors, Oxford Nanopore Technologies, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next generation sequencing platform...

DNA Sequencing Unicorn Oxford Nanopore Raises £100M Round at £1.5Bn Valuation

Undeterred by competitors, Oxford Nanopore, one of the few unicorns in the biotech space, has secured £100M (€113M) to continue growing its unique next-generation sequencing platform. Oxford Nano...

Drugs and Medications [0 Results]


PubMed Articles [833 Associated PubMed Articles listed on BioPortfolio]

Genetically Encoded Biosensors in Plants: Pathways to Discovery.

Genetically encoded biosensors that directly interact with a molecule of interest were first introduced more than 20 years ago with fusion proteins that served as fluorescent indicators for calcium io...

Film bulk acoustic resonators (FBARs) as biosensors: A review.

Biosensors play important roles in different applications such as medical diagnostics, environmental monitoring, food safety, and the study of biomolecular interactions. Highly sensitive, label-free a...

Simultaneous detection and determination of mercury (II) and lead (II) ions through the achievement of novel functional nucleic acid-based biosensors.

The serious threats of mercury (Hg) and lead (Pb) ions for the public health makes it important to achieve the detection methods of the ions with high affinity and specificity. Metal ions usually coex...

Gold nanoparticle-based colorimetric biosensors.

Gold nanoparticles (AuNPs) provide excellent platforms for the development of colorimetric biosensors as they can be easily functionalised, displaying different colours depending on their size, shape ...

Hyperspectral imaging for simultaneous measurements of two FRET biosensors in pancreatic β-cells.

Fluorescent protein (FP) biosensors based on Förster resonance energy transfer (FRET) are commonly used to study molecular processes in living cells. There are FP-FRET biosensors for many cellular mo...

Clinical Trials [92 Associated Clinical Trials listed on BioPortfolio]

Oxford Partial Knee Replacement. A Randomized Clinical Trial of Three Implant Types

The purpose of this scientific study is to clarify whether there is a relationship between the appearance of radiolucent lines in bone-cement interphase of the tibial component of the diff...

Comparison of Oxford UKA and Sigma UKA With RSA.

Comparison of two unicompartmental knee arthroplasties (UKA), to see if Sigma UKA performs equally good as the Oxford UKA. The study focuses on how well the arthroplasty is fixated to the ...

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in th...

Oxford® Partial Knee Kinematics Gait Analysis Study

The objective of this study is to compare the effect on gait of unicompartmental knee arthroplasty (UKA), using the Oxford® Partial Knee, versus total knee arthroplasty (TKA), using the V...

Outcome Analysis of the Oxford Partial Knee Arthroplasty

Prospectively monitor the patients receiving the Oxford Partial knee arthroplasty

Companies [118 Associated Companies listed on BioPortfolio]

Oxford Biosensors Ltd

Since formation in 2000, Oxford Biosensors has invested significant resources into the commercialisation of biosensor technology. The groundbreaking technical advances achieved through an intensive R ...

Oxford Resource Partners, LP

Oxford Resource Partners, LP is a low cost producer of high value steam coal in Northern Appalachia and the Illinois Basin. Oxford markets its coal primarily to large electric utilities with coal-fir...

Oxford Healthcare Technology

Oxford Healthcare Technology is a staffing firm that leverages their recruiting expertise to deliver experienced healthcare professionals and project teams for consulting engageme...

Oxford Lasers, Inc.

Since 1977, Oxford Lasers has been supplying laser solutions to science and industry. Oxford Lasers was founded in 1977 by physicists from Oxford University whose research had been directed towards th...

M-Biotech, Inc.

M-Biotech was founded in 1997 and is located in Salt Lake City, Utah. M-Biotech's core business includes the research and development of biosensors for health care applications. Based on M-Biotech's p...

More Information about "Oxford Biosensors Ltd" on BioPortfolio

We have published hundreds of Oxford Biosensors Ltd news stories on BioPortfolio along with dozens of Oxford Biosensors Ltd Clinical Trials and PubMed Articles about Oxford Biosensors Ltd for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Oxford Biosensors Ltd Companies in our database. You can also find out about relevant Oxford Biosensors Ltd Drugs and Medications on this site too.

Quick Search


Relevant Topic

Enzymes are proteins that catalyze (i.e., increase the rates of) chemical reactions. In enzymatic reactions, the molecules at the beginning of the process, called substrates, are converted into different molecules, called products. Almost all chemical re...

Corporate Database Quicklinks

Searches Linking to this Company Record